The Journal of Inflammation is a peer-reviewed, open-access journal dedicated to advancing our understanding of inflammation's fundamental mechanisms and clinical implications. Its scope encompasses basic, translational, and clinical research, aiming to bridge the gap between laboratory discoveries and improved patient outcomes. The journal provides a forum for scientists and clinicians to share their latest findings and insights into inflammatory processes.
Key topics covered include molecular pathways, cell signaling, animal models of inflammation, and clinical studies of inflammatory diseases. The journal particularly welcomes research on novel therapeutic targets and strategies for treating inflammatory conditions. It is indexed in major databases, including PubMed and Scopus, ensuring broad visibility and accessibility of its content. Its target audience includes researchers, clinicians, and pharmaceutical scientists working in the field of inflammation.
The Journal of Inflammation contributes significantly to the advancement of knowledge in this critical area of biomedical research. It provides a platform for disseminating cutting-edge research, fostering collaboration, and ultimately improving the lives of patients affected by inflammatory diseases. Researchers are encouraged to submit their innovative work to this highly regarded journal.